Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
about
Peri-operative management of an adult patient with type 2N von Willebrand's disease scheduled for coronary artery bypass graftDiagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of ThroProphylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and EHemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand diseaseVon Willebrand's disease: clinical management.Management of inherited von Willebrand disease in 2007.Prophylaxis of bleeding episodes in patients with von Willebrand's disease.A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance.Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis.Interaction between VWF and FVIII in treating VWD.Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.The 80th anniversary of von Willebrand's disease: history, management and research.Safety and efficacy of a von Willebrand factor/factor VIII concentrate (Wilate®): a single centre experience.Pharmacokinetics-based clinical management of acquired von Willebrand syndrome: a case report.Administration of plasma-derived coagulation factor VIII during the perioperative period of mastectomy for breast cancer with acquired von Willebrand syndrome
P2860
Q28221381-834C68A7-BD3C-4511-AA4B-D6BC43C8B9ADQ30315531-4F019571-7F11-4B14-9BC7-FCB2C83D3FB3Q30640740-30728939-11DC-4991-A86C-883A500F134FQ36193201-04945929-3B96-4010-91A1-1C2AB0C71E5FQ36473103-EB4DA760-F4D0-4DE7-B8EA-2988F0A95CA2Q36911419-B12C829E-3866-41F0-803B-9713E35E86F8Q37119655-A55366B3-EC46-46AC-9724-A9418480FA79Q37124978-6DB4D9FC-4147-4A77-9CAA-8234C2B30821Q37671400-67C62906-2AB0-48E4-9C41-62BB6C97BEEEQ38326080-B6247A99-3781-43AB-A250-0A2017841B79Q38953180-9122F90A-0A3B-4A77-8204-8229D43060C4Q45863536-4483E151-7F6F-4490-943E-B4C6C0103AFAQ45867482-8A8B90C8-1DCF-472B-9B3B-8D3D37877E26Q49752171-5A10B9ED-A464-4D9E-B88B-929C897E46EDQ58734525-9F35F711-674C-42D3-A3E2-9D750E1D1193
P2860
Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Management of von Willebrand d ...... m current studies and surveys.
@ast
Management of von Willebrand d ...... m current studies and surveys.
@en
type
label
Management of von Willebrand d ...... m current studies and surveys.
@ast
Management of von Willebrand d ...... m current studies and surveys.
@en
prefLabel
Management of von Willebrand d ...... m current studies and surveys.
@ast
Management of von Willebrand d ...... m current studies and surveys.
@en
P1476
Management of von Willebrand d ...... m current studies and surveys.
@en
P2093
Augusto B Federici
P304
P356
10.1097/01.MBC.0000167658.85143.49
P478
16 Suppl 1
P577
2005-04-01T00:00:00Z